Volume 20, Issue 1

Two studies received Best Investigator-Initiated Study Awards at ECCO’25. The first study, entitled “Low remission recapture after ustekinumab dose optimization in Crohn’s disease: results of the randomized placebo-controlled double-blind REScUE study”, was led by Peter Bossuyt and colleagues from Belgium.

A total of 130 abstracts focused on epidemiology were selected for presentation at the 2025 ECCO Congress, the highest number submitted in this category in recent years. This growth underscores the importance that ECCO Members and IBD researchers place on epidemiology in deepening our understanding of IBD aetiology, management and outcomes. In this article, we spotlight some of the most noteworthy abstracts that stood out to us during the recent ECCO Congress in Berlin (see graph).

The 12th ECCO Ultrasound Workshop – Advanced, organised in collaboration with ESGAR and IBUS, took place during the 20th Congress of ECCO in Berlin in February 2025 as part of ECCO's Educational Programme. The workshop was attended by 166 participants and brought together experts from various countries, facilitating valuable discussions on the latest advancements in intestinal ultrasound (IUS) for Inflammatory Bowel Disease (IBD).

Ultrasound and MRI Focus The 6th ECCO Workshop on Imaging, a key part of ECCO's Educational Programme, took place during the 20th Congress of ECCO in Berlin in February 2025. Due to high interest, two identical sessions were held on the same day, allowing more participants to take part in this hands-on learning course. We thank all the speakers and tutors, whose expertise and dedication contributed to the success of the event.

The 4th ECCO Postgraduate Course in IBD was successfully held on-site during the 20th ECCO Congress in Berlin in February 2025. The course was split into two sessions, with the first session, entitled “Prepare yourself with the experts”, focusing on common complications in IBD practice, which were presented by renowned speakers who are key opinion leaders in the field.

The European Crohn’s and Colitis Organisation (ECCO), in collaboration with the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS), has released an updated version of its multi-society guidelines on the diagnostics and monitoring of Inflammatory Bowel Disease (IBD).